Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$135M |
| 2 |
VER
VEREIT, Inc.
VER
|
+$60.1M |
| 3 |
KSU
Kansas City Southern
KSU
|
+$51.2M |
| 4 |
SCR
Score Media and Gaming Inc. Class A Subordinate Voting Shares
SCR
|
+$30.7M |
| 5 |
XOG
Extraction Oil & Gas, Inc. Common Stock
XOG
|
+$25.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$167M |
| 2 |
NAV
Navistar International
NAV
|
+$89.6M |
| 3 |
PPD
PPD, Inc. Common Stock
PPD
|
+$86.9M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$80M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$48.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Financials | 10.75% |
| 3 | Industrials | 8.87% |
| 4 | Healthcare | 8.5% |
| 5 | Real Estate | 7.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRNS
226
Barinthus Biotherapeutics
BRNS
$25.4M
| $5.73M | 0.09% |
378,260
-42,059
| -10% | -$639K |
|
227
DuPont de Nemours
DD
$18.7B
| $5.68M | 0.09% |
66,548
+18,974
| +40% | +$1.76M |
|
228
Masco
MAS
$14.5B
| $5.64M | 0.09% |
101,485
-39,664
| -28% | -$2.35M |
|
229
Aecom
ACM
$8.34B
| $5.63M | 0.09% |
89,177
+55,327
| +163% | +$3.52M |
|
230
CALL
Tesla
TSLA
$1.43T
| $5.59M | 0.09% |
+21,600
| New | +$5.08M |
|
231
TE Connectivity
TEL
$58.9B
| $5.59M | 0.09% |
40,732
+36,246
| +808% | +$5.23M |
|
232
FNB Corp
FNB
$6.6B
| $5.57M | 0.09% |
+479,134
| New | +$5.52M |
|
233
PUT
Berkshire Hathaway Class B
BRK.B
$1.06T
| $5.57M | 0.09% |
+20,400
| New | +$5.73M |
|
234
Cable One
CABO
$129M
| $5.52M | 0.09% |
3,046
+2,259
| +287% | +$4.43M |
|
235
California Resources
CRC
$4.73B
| $5.52M | 0.09% |
134,626
+19,182
| +17% | +$626K |
|
236
Parker-Hannifin
PH
$126B
| $5.51M | 0.09% |
19,719
+3,104
| +19% | +$923K |
|
237
ASML
ASML
$677B
| $5.49M | 0.09% |
7,372
+877
| +14% | +$689K |
|
238
PUT
Honeywell
HON
$68.4B
| $5.48M | 0.09% |
27,374
-1,061
| -4% | -$226K |
|
239
Voya Financial
VOYA
$8.86B
| $5.42M | 0.09% |
88,285
+74,625
| +546% | +$4.75M |
|
240
Asana
ASAN
$2.21B
| $5.4M | 0.09% |
52,008
+5,317
| +11% | +$441K |
|
|
LOCC.U
241
DELISTED
Live Oak Crestview Climate Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-third of one warrant
LOCC.U
| $5.4M | 0.09% |
+550,000
| New | +$5.41M |
|
|
PXD
242
DELISTED
Pioneer Natural Resource Co.
PXD
| $5.39M | 0.09% |
+32,390
| New | +$4.9M |
|
|
SAFE
243
DELISTED
Safehold Inc.
SAFE
| $5.38M | 0.09% |
+74,902
| New | +$6.35M |
|
244
Vertex Pharmaceuticals
VRTX
$139B
| $5.38M | 0.09% |
+29,658
| New | +$5.79M |
|
245
Intel
INTC
$476B
| $5.36M | 0.09% |
100,651
-54,534
| -35% | -$2.96M |
|
246
Alnylam Pharmaceuticals
ALNY
$31.6B
| $5.33M | 0.09% |
+28,253
| New | +$5.3M |
|
247
Live Nation Entertainment
LYV
$42.4B
| $5.33M | 0.09% |
58,451
+55,786
| +2,093% | +$4.7M |
|
248
Brighthouse Financial
BHF
$3.01B
| $5.31M | 0.09% |
+117,489
| New | +$5.3M |
|
249
PUT
IBM
IBM
$222B
| $5.3M | 0.09% |
+39,853
| New | +$5.33M |
|
250
Lam Research
LRCX
$393B
| $5.3M | 0.09% |
93,050
+27,030
| +41% | +$1.64M |
|
Similar funds
Paul Tudor Jones's Q3 2021 Portfolio in Review
As of Q3 2021, Paul Tudor Jones held 3,006 positions worth $6.16B, up 16% from $5.29B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Paul Tudor Jones deployed $1.01B of net new capital in Q3 2021, opening 1,436 new positions and adding to 429 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 305,273 shares worth $131M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was PPD, Inc. Common Stock, an estimated $86.9M trimmed.
- Paul Tudor Jones's largest Q3 2021 buy was State Street SPDR S&P 500 ETF Trust: 305,273 shares worth $131M.
- Paul Tudor Jones added most to Kansas City Southern in Q3 2021, an estimated $51.2M increase.
- Paul Tudor Jones's biggest Q3 2021 reduction was PPD, Inc. Common Stock, cutting an estimated $86.9M.
- Paul Tudor Jones fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $167M.
- Paul Tudor Jones's ten largest holdings make up 13% of its $6.16B portfolio in Q3 2021.
- Paul Tudor Jones opened 1,436 new positions and closed 597 in Q3 2021.
- Paul Tudor Jones's portfolio value rose 16% quarter-over-quarter to $6.16B.
Based on Tudor Investment Corp's 13F filing for Q3 2021, filed 15 Nov 2021.